← Back to Search

Behavioural Intervention

AYA Connect-PP for Cancer Survivorship (AYAConnect Trial)

N/A
Recruiting
Led By Carmina Valle, PhD
Research Sponsored by UNC Lineberger Comprehensive Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosed with first invasive cancer between the ages of 15-39 years old
Currently age 18-39
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at 3 and 6 month
Awards & highlights

AYAConnect Trial Summary

This trial aims to see if using a mobile app to track diet, exercise, and weight can help adolescent and young adult cancer survivors lose weight. #weightloss #AYAs #cancer

Who is the study for?
This trial is for young adult cancer survivors who are dealing with weight issues. Participants should be interested in using a mobile app to help with weight loss and increasing physical activity.Check my eligibility
What is being tested?
The study tests three interventions: AYA Connect, Positive Psychology (PP), and Positive Psychology Plus (PP+). All use a smartphone app integrating diet monitoring and activity tracking to support weight loss.See study design
What are the potential side effects?
Since this trial focuses on lifestyle changes through an app, side effects may include typical exercise-related discomfort or stress from dietary changes but no medical side effects like those from drugs.

AYAConnect Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I was diagnosed with my first invasive cancer between 15-39 years old.
Select...
I am between 18 and 39 years old.
Select...
It's been less than 10 years since my diagnosis, and my cancer hasn't worsened or spread.

AYAConnect Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 3 and 6 month
This trial's timeline: 3 weeks for screening, Varies for treatment, and at 3 and 6 month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Feasibility of interventions as measured by accrual rate
Feasibility of interventions as measured by participation rate
Feasibility of interventions as measured by retention rate
Secondary outcome measures
Acceptability of Young Adult Cancers (AYAs) Connect
Adherence to dietary tracking
Adherence to physical activity monitoring
+17 more

AYAConnect Trial Design

3Treatment groups
Experimental Treatment
Group I: AYA Connect-PP+Experimental Treatment3 Interventions
Adolescent and young adult cancer survivors receive AYA Connect-PP+ intervention.
Group II: AYA Connect-PPExperimental Treatment2 Interventions
Adolescent and young adult cancer survivors receive AYA Connect-PP intervention.
Group III: AYA ConnectExperimental Treatment1 Intervention
Adolescent and young adult cancer survivors receive AYA Connect intervention.

Find a Location

Who is running the clinical trial?

UNC Lineberger Comprehensive Cancer CenterLead Sponsor
351 Previous Clinical Trials
88,273 Total Patients Enrolled
Carmina Valle, PhDPrincipal InvestigatorUNC Lineberger Comprehensive Cancer Center
1 Previous Clinical Trials
49 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any qualifications that would allow me to participate in this medical experiment?

"To be accepted to this study, applicants must possess an active lifestyle and fall within the 18-39 age range. Approximately 60 individuals are necessary for enrolment in this clinical trial."

Answered by AI

Does this research project permit those over the age of sixty to participate?

"This clinical trial is currently recruiting individuals aged 18 to 39 years old."

Answered by AI

What are the aims of this medical experiment?

"The primary outcome of the trial, to be assessed at 3 months from baseline, is assessing the efficacy of interventions as gauged by patient retention rate. Secondary objectives comprise changes in anxiety symptoms (as measured using GAD-7 scale), weight alterations (calculated with a smart scale) and depressive symptomatology(utilizing CES-D)."

Answered by AI

Are there vacancies in the trial for participants?

"According to the clinicaltrials.gov listing, this medical study is not currently accepting patients. It appears that it opened on December 1st of 2023 and was last edited a few weeks later on December 12th. However, there are 1786 other studies actively recruiting participants presently."

Answered by AI
~40 spots leftby Nov 2024